Literature DB >> 30730519

Telescoped synthesis of C3-functionalized (E)-arylamidines using Ugi-Mumm and regiospecific quinazolinone rearrangements.

Victor A Jaffett1, Alok Nerurkar, Xufeng Cao, Ilia A Guzei, Jennifer E Golden.   

Abstract

An efficient four-step, six-transformation protocol was developed to afford bioactive N-alkyl- or N-arylamide (E)-arylamidines featuring strategic amidine C3 modifications which were inaccessible or low yielding by previous methods. This synthetic approach, exemplified with 24 amidines and requiring only a single purification, highlights a multicomponent Ugi-Mumm rearrangement to afford highly diversified quinazolinones which undergo regiospecific rearrangement to afford new amidines. The method extensively broadens the structural scope of this new class of trisubstituted amidines and demonstrates the tolerance of regional C3 amidine steric bulk, visualized with X-ray crystallographic analysis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30730519      PMCID: PMC6426674          DOI: 10.1039/c9ob00073a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  30 in total

1.  One-pot, regiospecific assembly of (E)-benzamidines from δ- and γ-amino acids via an intramolecular aminoquinazolinone rearrangement.

Authors:  Chad E Schroeder; Sarah A Neuenswander; Tuanli Yao; Jeffrey Aubé; Jennifer E Golden
Journal:  Org Biomol Chem       Date:  2016-04-06       Impact factor: 3.876

2.  Imides: forgotten players in the Ugi reaction. One-pot multicomponent synthesis of quinazolinones.

Authors:  Riccardo Mossetti; Tracey Pirali; Dèsirèe Saggiorato; Gian Cesare Tron
Journal:  Chem Commun (Camb)       Date:  2011-05-17       Impact factor: 6.222

3.  Seven-component reactions by sequential chemoselective Ugi-Mumm/Ugi-Smiles reactions.

Authors:  Sebastian Brauch; Lars Gabriel; Bernhard Westermann
Journal:  Chem Commun (Camb)       Date:  2010-03-19       Impact factor: 6.222

Review 4.  Olanzapine versus other atypical antipsychotics for schizophrenia.

Authors:  Katja Komossa; Christine Rummel-Kluge; Heike Hunger; Franziska Schmid; Sandra Schwarz; Lorna Duggan; Werner Kissling; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

5.  The use of the Ugi four-component condensation.

Authors:  Stefano Marcaccini; Tomás Torroba
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

6.  The pharmacodynamics of bucainide (RHC G233): pharmacokinetic parameters and relationship between plasma levels and the effect on the electrocardiogram in the dog.

Authors:  P Grebow; W Feeney; M Johnston; J Lettieri; H Li; E Magnien; P O'Brien; R Swillo; I Weinryb; P Wolf; J C Marsiglia
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1981-06

7.  A controlled comparative trial of a new antidepressant, ciclazindol.

Authors:  S Levine
Journal:  J Int Med Res       Date:  1979       Impact factor: 1.671

8.  Biochemical and pharmacological effects of fluperlapine on noradrenaline and acetylcholine systems in some rodent, bovine and crustacean preparations.

Authors:  C Rüdeberg; S Urwyler; C Schulthess; P L Herrling
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

9.  Olanzapine and haloperidol for the treatment of acute symptoms of mental disorders induced by amphetamine-type stimulants: A randomized controlled trial.

Authors:  Xiaobin Xue; Yun Song; Xiaojie Yu; Qiang Fan; Jiyou Tang; Xu Chen
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

10.  Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2.

Authors:  Dong-Hoon Chung; Colleen B Jonsson; Nichole A Tower; Yong-Kyu Chu; Ergin Sahin; Jennifer E Golden; James W Noah; Chad E Schroeder; Julie B Sotsky; Melinda I Sosa; Daniel E Cramer; Sara N McKellip; Lynn Rasmussen; E Lucile White; Connie S Schmaljohn; Justin G Julander; Jeffrey M Smith; Claire Marie Filone; John H Connor; Yasuteru Sakurai; Robert A Davey
Journal:  PLoS Pathog       Date:  2014-06-26       Impact factor: 6.823

View more
  3 in total

1.  Divergent 2-Chloroquinazolin-4(3H)-one Rearrangement: Twisted-Cyclic Guanidine Formation or Ring-Fused N-Acylguanidines via a Domino Process.

Authors:  Gang Yan; Bereket L Zekarias; Xiaoyu Li; Victor A Jaffett; Ilia A Guzei; Jennifer E Golden
Journal:  Chemistry       Date:  2020-02-06       Impact factor: 5.236

2.  Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones.

Authors:  Michael C Ryan; Eunjung Kim; Xufeng Cao; Walter Reichard; Tyler J Ogorek; Pronay Das; Colleen B Jonsson; Jerome Baudry; Donghoon Chung; Jennifer E Golden
Journal:  ACS Med Chem Lett       Date:  2022-03-14       Impact factor: 4.632

3.  Diastereoselective, Multicomponent Synthesis of Pyrrolopyrazinoquinazolinones via a Tandem Quinazolinone Rearrangement/Intramolecular Ring Closure of Tautomeric (Z)-Benzamidines.

Authors:  Victor A Jaffett; Jhewelle N Fitz-Henley; Muhammad M Khalifa; Ilia A Guzei; Jennifer E Golden
Journal:  Org Lett       Date:  2021-07-12       Impact factor: 6.072

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.